Discover 1,888 paid clinical trials in Georgia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Georgia presents extensive opportunities for healthy volunteers looking to participate in paid studies and individuals with specific health conditions alike. Research hubs in major cities like Atlanta, Augusta, and Savannah are actively recruiting participants, providing access to emerging therapies and top-tier medical care.
Filter
1
Filter results
Results: 1,888
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
for
Neurotrophic Keratopathy
Location: Danbury CT, The Bronx NY, Palisades Park NJ, Norfolk VA,
Sponsor: ReGenTree, LLC
Sex: All
Age: 18+
Code: NCT05555589
Phase3, Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Location: Boston MA, Montreal, Philadelphia PA, Baltimore MD,
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0 - 17
Code: NCT06651580
Recruiting
Progesterone in Gender Affirming Hormone Therapy Study
for
Transgender Women
Location: Atlanta GA
Sponsor: Emory University
Sex: Male
Age: 18 - 60
Code: NCT06807580
Phase2, Recruiting
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
for
Epiretinal Membrane
Location: Boston MA, Ayer MA, Philadelphia PA, Baltimore MD,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 50+
Code: NCT05145491
Recruiting
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
for
Amblyopia
Location: Concord NH, Philadelphia PA, Maitland FL, Savannah GA,
Sponsor: Luminopia
Sex: All
Age: 0+
Code: NCT06429280
Recruiting
Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age
for
HIV-1-infection
Location: Atlanta GA, Memphis TN
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 2 - 11
Code: NCT05660980
Phase1, Phase2, Recruiting
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease